UK Markets open in 3 hrs 23 mins

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
519.10-0.40 (-0.08%)
At close: 4:59PM CEST
Sign in to post a message.
  • P
    Patti
    "Buy on rumor, sell on news" , is the stock market gospel !
  • a
    ahlbrandt
    I don’t know how I ever traded without using (http://Thetraderguide.com)! I look forward to their daily emails each morning that list pre-market movers based on thoroughly researched stock market and world news. I highly recommend anyone who invests in the stock market!
  • L
    LQMark
    NVO is a no-brainer buy here. Compared to BIIB Alzheimer drug, Wegovy has a bigger market, is affordable and actually works. The folks at NVO are super conservative about marketing...one analyst said they like to bury good news in footnotes. So you have to be patient. NVO is a good company, fairly valued with a solid dividend...its like you get a nice upside option for free. Good stock to buy and forget...likely to inch up higher for years.
  • E
    Eric
    It's pretty cool to go down in stock price, after FDA approval.
  • J
    Joseph
    What is going on... Are people not seeing the FDA news or is it because I bought?
  • g
    greg
    Did anyone notice the spike in after hours to over $90 upon approval of Wegovy on 6/4/21? Just a glimpse into the bright future.
  • p
    peachbacks
    A 15% weight in half the we1stern population would be better than or equal to a near real good drug for Alzheimer’s .
  • L
    Lula
    Mark my words, a split is coming. Will it be 2 for 1, 4 for 1, or 5 for 1? NVO has done each of those scenarios.
  • L
    LesJ
    People suffering from obesity will have to take the drug for life to manage their weight, while ceasing to take it could lead to regaining most of the lost weight, according to one of the trials. revenue for life. wish ida bought more
  • T
    ToykoJoe
    Yes! 100 soon. This one will be a winner. Weight loss market is 70 billion and most if not 90% is a gimmick and people know that. More people gonna be in line than hot the COVID shot.
  • E
    Eric
    Does or did NVO have a dividend?
  • B
    Bjarne
    Approved!!!!!
  • B
    Bjarne
    This stock will be 100$ soon
  • B
    Benny Lane
    News just now hitting national outlets. 20-30 percent rise Monday at least
  • L
    Linwood
    Anyone have projections on Wegovy potential yearly revenue? A lot "ifs" involved I know but WOW my head spins when I think about the possibilities for this drug. Once coverage is adopted I'm thinking anywhere between 2 and 10 billion a month. Yes, I said 10 billion a month.
  • p
    peachbacks
    There is a market and insurance will cover those with significant weight issues, The potential market for those not covered is huge and it will be price sensitive. Pricing at $ 1000, 750, 500, or 250 a month will have a dramatic influence on the number of users.
  • b
    blackoutbuzz
    Goldman says buy. Target DKK 517 and it's trading at 498 DKK today. Don't stick your neck out to far there Mr. Goldman.

    @@@06/07/2021 | 09:50am EDT In a research note published by Keyur Parekh, Goldman Sachs advises its customers to buy the stock. The target price is unchanged at DKK 517.

    https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/news/NOVO-NORDISK-nbsp-Goldman-Sachs-reiterates-its-Buy-rating-35538705/
  • M
    Mark
    this stock should be much higher. bargain imo
  • T
    TheeJew
    I thought something like this is worth more than $2.5 pup ...is this a bad sign ?